REQUEST A DEMO
Total
USD $0.00
Search more companies

Midmeding Nova D.O.O. Beograd (Serbia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Midmeding Nova D.O.O. Beograd Profile Updated: October 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Midmeding Nova D.O.O. Beograd is an enterprise in Serbia, with the main office in Belgrade. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. Midmeding Nova D.O.O. Beograd was incorporated on 2011. It currently has a total number of 16 (2023) employees. In its most recent financial highlights, the company reported a net sales revenue increase of 8.48% in 2023. There was a total growth of 29.07% in Midmeding Nova D.O.O. Beograd’s total assets over the same period. The net profit margin of Midmeding Nova D.O.O. Beograd increased by 3.27% in 2023.

Headquarters
Milosev Kladenac 9 V
Belgrade; Belgrade;

Contact Details: Purchase the Midmeding Nova D.O.O. Beograd report to view the information.

Website: http://CUBE_PROFILES_YU

Basic Information
Total Employees:
Purchase the Midmeding Nova D.O.O. Beograd report to view the information.
Outstanding Shares:
Purchase the Midmeding Nova D.O.O. Beograd report to view the information.
Registered Capital:
Purchase the Midmeding Nova D.O.O. Beograd report to view the information.
Incorporation Date:
2011
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Laboratorija Ivancic I Sin
100%
Company Performance
Financial values in the chart are available after Midmeding Nova D.O.O. Beograd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
8.48%
Total operating revenue
8.45%
Operating profit (EBIT)
95.54%
EBITDA
88.9%
Net Profit (Loss) for the Period
124.47%
Total assets
29.07%
Total equity
76.68%
Operating Profit Margin (ROS)
2.05%
Net Profit Margin
3.27%
Return on Equity (ROE)
9.44%
Debt to Equity Ratio
-13.1%
Quick Ratio
0.2%
Cash Ratio
0.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?